Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04331509 · ClinicalTrials.gov registry record

COVID-19 Symptom Tracker

A clinical trial of COVID-19, sponsored by King's College London.

Active
Registry status
10,000,000
Enrollment target
2
Study locations

NCT04331509 is a study of COVID-19 that is active but no longer recruiting, run by King's College London. The registered enrollment target is 10,000,000 participants, above the 5,953-participant average among 203 other COVID-19 trials with a reported enrollment target (167883% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04331509, a study of COVID-19, is active but no longer recruiting, sponsored by King's College London.

ACTIVE NOT RECRUITING
Registry status
10,000,000 participants
Enrollment target
2
Study locations

Study Summary

The viral Covid-19 outbreak is now considered a pandemic according to the World Health Organisation (WHO). A free monitoring app 'COVID-19 Symptom Tracker' has been developed to record and monitor the symptoms of the COVID-19 coronavirus infection; tracking in real time how the disease progresses. The app also records how measures aimed at controlling the pandemic including self-isolation and distancing are affecting the mental health and well-being of participants. The data from the study will reveal important information about the symptoms and progress of COVID-19 infection in different people, and why some go on to develop more severe or fatal disease while others have only mild symptoms do not.

Conditions Studied

COVID-19

Interventions

  • OTHER No Intervention

Study Locations (2)

Massachusetts

  • Massachusetts General Hospital - Boston

London

  • King's College London - London

Trial Details

FieldValue
Enrollment Target 10,000,000 participants
Start Date 2020-03-23
Est. Completion 2026-03-23

Sponsor

King's College London

5 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04331509

The ClinicalTrials.gov registry entry for NCT04331509 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 5,953-participant average among 203 other COVID-19 trials with a reported enrollment target (167883% higher). The listed sponsor is King's College London, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which No Intervention is the first listed.

NCT04331509 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, London.

Frequently Asked Questions

What is clinical trial NCT04331509 about?

NCT04331509 is a clinical study titled "COVID-19 Symptom Tracker". The viral Covid-19 outbreak is now considered a pandemic according to the World Health Organisation (WHO). A free monitoring app 'COVID-19 Symptom Tracker' has been developed to record and monitor the symptoms of the COVID-19 coronavirus infection; tracking in real time how the disease progresses. T...

What is the current status of trial NCT04331509?

This trial is currently active not recruiting. The enrollment target is 10,000,000 participants. The study started on 2020-03-23. Estimated completion is 2026-03-23.

What conditions does trial NCT04331509 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT04331509?

The interventions under investigation include: No Intervention (OTHER).

Who is sponsoring clinical trial NCT04331509?

This trial is sponsored by King's College London, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04331509 being conducted?

This trial has 2 study locations across Massachusetts, London. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

COVID-19

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.